Document is current
Any future updates will be listed below
-
Authors
Ritchie, Marina
Gillen, Daniel L.
Grill, Joshua D.
- License Information
-
More Information
Article History
Received: 18 October 2022
Accepted: 23 January 2023
First Online: 2 February 2023
Declarations
:
: Each trial conducted by the ADCS for which data were analyzed was approved by a local IRB. Informed consent was obtained from all trial participants at each participating site in each trial. The analyses for the current study only used de-identified data and therefore do not meet the criteria for human subjects research.
: We have received approval to publish our results from the ADCS and the Alzheimer’s Therapeutic Research Institute (the two organizations that provided us with data).
: M.R. and D.L.G. declare that they have no competing interests. J.D.G. reports research support from Eli Lilly, Genentech, Biogen, Eisai, NIA, the Alzheimer’s Association, and BrightFocus Foundation; he has provided consulting to SiteRx, Cogniciti, and Flint Rehab.
